- Home
- ACIU vs TTSH Comparison
ACIU vs TTSH Comparison
Compare ACIU & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- TTSH
- Stock Information
- Founded
- ACIU 2003
- TTSH 1985
- Country
- ACIU Switzerland
- TTSH United States
- Employees
- ACIU N/A
- TTSH N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- TTSH Blank Checks
- Sector
- ACIU Health Care
- TTSH Finance
- Exchange
- ACIU Nasdaq
- TTSH Nasdaq
- Market Cap
- ACIU 332.4M
- TTSH 295.2M
- IPO Year
- ACIU 2016
- TTSH N/A
- Fundamental
- Price
- ACIU $2.71
- TTSH $6.66
- Analyst Decision
- ACIU Strong Buy
- TTSH
- Analyst Count
- ACIU 2
- TTSH 0
- Target Price
- ACIU $12.00
- TTSH N/A
- AVG Volume (30 Days)
- ACIU 130.0K
- TTSH 188.2K
- Earning Date
- ACIU 11-05-2024
- TTSH 11-07-2024
- Dividend Yield
- ACIU N/A
- TTSH N/A
- EPS Growth
- ACIU N/A
- TTSH N/A
- EPS
- ACIU N/A
- TTSH 0.08
- Revenue
- ACIU $48,505,404.00
- TTSH $352,075,000.00
- Revenue This Year
- ACIU $85.33
- TTSH $8.17
- Revenue Next Year
- ACIU $80.69
- TTSH N/A
- P/E Ratio
- ACIU N/A
- TTSH $82.09
- Revenue Growth
- ACIU 4097200.00
- TTSH N/A
- 52 Week Low
- ACIU $2.25
- TTSH $5.68
- 52 Week High
- ACIU $5.14
- TTSH $7.50
- Technical
- Relative Strength Index (RSI)
- ACIU 29.89
- TTSH 46.68
- Support Level
- ACIU $2.62
- TTSH $6.44
- Resistance Level
- ACIU $3.07
- TTSH $6.98
- Average True Range (ATR)
- ACIU 0.15
- TTSH 0.25
- MACD
- ACIU -0.04
- TTSH -0.02
- Stochastic Oscillator
- ACIU 17.24
- TTSH 37.93
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About TTSH Tile Shop Holdings Inc.
Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers, and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.